9,045 Shares in Sanofi (NASDAQ:SNY) Purchased by Kentucky Trust Co

Kentucky Trust Co acquired a new position in Sanofi (NASDAQ:SNY) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 9,045 shares of the company’s stock, valued at approximately $436,000.

Several other hedge funds have also recently bought and sold shares of SNY. Synergy Asset Management LLC purchased a new stake in Sanofi in the 4th quarter worth about $25,000. Northwest Investment Counselors LLC purchased a new stake in Sanofi in the 3rd quarter worth about $29,000. Concord Wealth Partners lifted its stake in Sanofi by 157.8% in the 3rd quarter. Concord Wealth Partners now owns 593 shares of the company’s stock worth $34,000 after acquiring an additional 363 shares in the last quarter. Fortitude Family Office LLC lifted its stake in Sanofi by 708.6% in the 3rd quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock worth $43,000 after acquiring an additional 659 shares in the last quarter. Finally, Sunbelt Securities Inc. lifted its stake in Sanofi by 72.1% in the 3rd quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock worth $43,000 after acquiring an additional 313 shares in the last quarter. 14.04% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft raised Sanofi from a “sell” rating to a “hold” rating in a research report on Thursday, January 30th. StockNews.com lowered Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Finally, Sanford C. Bernstein raised Sanofi to a “strong-buy” rating in a research report on Thursday, January 30th. Two investment analysts have rated the stock with a hold rating, one has issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $60.00.

Sanofi Stock Performance

Shares of SNY stock opened at $53.90 on Wednesday. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.46 and a quick ratio of 0.74. Sanofi has a fifty-two week low of $45.22 and a fifty-two week high of $58.97. The stock’s 50-day moving average is $49.94 and its two-hundred day moving average is $52.40. The firm has a market cap of $136.79 billion, a P/E ratio of 21.65, a PEG ratio of 0.99 and a beta of 0.57.

Sanofi (NASDAQ:SNY) last issued its quarterly earnings data on Thursday, January 30th. The company reported $0.70 EPS for the quarter, meeting analysts’ consensus estimates of $0.70. Sanofi had a return on equity of 25.58% and a net margin of 12.77%. Analysts predict that Sanofi will post 4.36 earnings per share for the current fiscal year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.